These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1531817)

  • 21. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.
    Gaynes BN
    J Clin Psychiatry; 2009; 70 Suppl 6():10-5. PubMed ID: 19922739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.
    Mertens C; Pintens H
    Acta Psychiatr Scand; 1988 Jun; 77(6):683-8. PubMed ID: 2970203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First results of an open phase II study with the antidepressant paroxetine.
    Stuppäck C; Schubert H; Barnas C; Mair M; Schifferle I; Unterweger B; Wömhart L; Fleischhacker WW; Hinterhuber H
    Pharmacopsychiatry; 1988 Nov; 21(6):369-70. PubMed ID: 2977442
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of lithium to augment antidepressant medication.
    Rouillon F; Gorwood P
    J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients.
    Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW
    J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic dose range of nefazodone in the treatment of major depression.
    Robinson DS; Marcus RN; Archibald DG; Hardy SA
    J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time course of response to paroxetine: influence of plasma level.
    Gex-Fabry M; Gervasoni N; Eap CB; Aubry JM; Bondolfi G; Bertschy G
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):892-900. PubMed ID: 17395353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of paroxetine on human sleep.
    Oswald I; Adam K
    Br J Clin Pharmacol; 1986 Jul; 22(1):97-9. PubMed ID: 2943309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics of paroxetine in elderly depressed patients.
    Ghose K
    Acta Psychiatr Scand Suppl; 1989; 350():87-8. PubMed ID: 2530797
    [No Abstract]   [Full Text] [Related]  

  • 33. The therapeutic efficacy of paroxetine: (a) an open study in patients with major depression not responding to antidepressants; (b) a double-blind comparison with amitriptyline in depressed outpatients.
    Gagiano CA; Müller PG; Fourie J; Le Roux JF
    Acta Psychiatr Scand Suppl; 1989; 350():130-1. PubMed ID: 2530765
    [No Abstract]   [Full Text] [Related]  

  • 34. A double-blind, multicentre study of paroxetine and mianserin in depression.
    Mertens C; Pintens H
    Acta Psychiatr Scand Suppl; 1989; 350():140. PubMed ID: 2530770
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of paroxetine on the electroencephalogram, electrocardiogram, and blood pressure.
    Edwards JG; Goldie A; Papayanni-Papasthatis S; Punter J; Sedgwick EM
    Acta Psychiatr Scand Suppl; 1989; 350():124. PubMed ID: 2530762
    [No Abstract]   [Full Text] [Related]  

  • 36. Consensus panel calls for vigorous treatment of depression in elderly.
    Hosp Community Psychiatry; 1992 Oct; 43(10):1049-50. PubMed ID: 1398576
    [No Abstract]   [Full Text] [Related]  

  • 37. Introduction to the development of paroxetine, a novel antidepressant.
    Lassen JB
    Acta Psychiatr Scand Suppl; 1989; 350():13. PubMed ID: 2530764
    [No Abstract]   [Full Text] [Related]  

  • 38. Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients.
    Byrne MM
    Acta Psychiatr Scand Suppl; 1989; 350():138-9. PubMed ID: 2530768
    [No Abstract]   [Full Text] [Related]  

  • 39. Circadian rhythm, depression, antidepressants, single dose.
    Herrmann L
    Pharmacopsychiatry; 1984 May; 17(3):69-70. PubMed ID: 6739536
    [No Abstract]   [Full Text] [Related]  

  • 40. New antidepressants and 5-HT uptake inhibitors.
    Montgomery SA
    Acta Psychiatr Scand Suppl; 1989; 350():107-16. PubMed ID: 2530760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.